Jin W, Brown S, Roche J P, Hsieh C, Celver J P, Kovoor A, Chavkin C, Mackie K
Department of Pharmacology, University of Washington, Seattle, Washington 98195-6540, USA.
J Neurosci. 1999 May 15;19(10):3773-80. doi: 10.1523/JNEUROSCI.19-10-03773.1999.
Desensitization of cannabinoid receptor signaling by a G-protein coupled receptor kinase (GRK) was examined using the Xenopus oocyte expression system. Application of a CB1 agonist, WIN 55,212-2, evoked a concentration-dependent increase in K+ conductance (Kir3) in oocytes coexpressing rat CB1 with the G-protein-gated, inwardly rectifying K+ channels Kir3.1 and Kir3.4. Desensitization was slight during continuous agonist application in the absence of GRK and arrestin. However, coexpression of GRK3 and beta-arrestin 2 (beta-arr2) caused profound homologous CB1 receptor desensitization, supporting the hypothesis that GRK3 and beta-arr2 effectively produce CB1 receptor desensitization. To identify the regions of the CB1 receptor responsible for GRK3- and beta-arr2-mediated desensitization, we constructed several CB1 receptor mutants. Truncation of the C-terminal tail of CB1 receptor at residue 418 (Delta418) almost completely abolished desensitization but did not affect agonist activation of Kir3. In contrast, truncation at residues 439 and 460 did not significantly affect GRK3- and beta-arr2-dependent desensitization. A deletion mutant (Delta418-439) did not desensitize, indicating that residues within this region are important for GRK3- and beta-arr2-mediated desensitization. Phosphorylation in this region was likely involved in desensitization, because mutation of either of two putative phosphorylation sites (S426A or S430A) significantly attenuated desensitization. CB1 receptors rapidly internalize after activation by agonist. Phosphorylation of S426 or S430 was not necessary for internalization, because the S426A/S430A CB1 mutant internalized when stably expressed in AtT20 cells. These studies establish that CB1 desensitization can be regulated by a GRK and that different receptor domains are involved in GRK- and beta-arrestin-dependent desensitization and CB1 internalization.
利用非洲爪蟾卵母细胞表达系统研究了G蛋白偶联受体激酶(GRK)对大麻素受体信号传导的脱敏作用。在共表达大鼠CB1与G蛋白门控内向整流钾通道Kir3.1和Kir3.4的卵母细胞中,应用CB1激动剂WIN 55,212-2可引起钾离子电导(Kir3)浓度依赖性增加。在没有GRK和抑制蛋白的情况下持续应用激动剂时,脱敏作用轻微。然而,GRK3和β-抑制蛋白2(β-arr2)的共表达导致CB1受体发生显著的同源脱敏,支持GRK3和β-arr2有效导致CB1受体脱敏的假说。为了确定CB1受体中负责GRK3和β-arr2介导的脱敏作用的区域,我们构建了几种CB1受体突变体。将CB1受体的C末端尾巴在第418位残基处截断(Δ418)几乎完全消除了脱敏作用,但不影响激动剂对Kir3的激活。相反,在第439和460位残基处截断对GRK3和β-arr2依赖性脱敏作用没有显著影响。一个缺失突变体(Δ418-439)不发生脱敏,表明该区域内的残基对GRK3和β-arr2介导的脱敏作用很重要。该区域的磷酸化可能参与了脱敏作用,因为两个假定的磷酸化位点(S426A或S430A)中的任何一个发生突变都会显著减弱脱敏作用。激动剂激活后,CB1受体迅速内化。S426或S430的磷酸化对于内化不是必需的,因为S426A/S430A CB1突变体在AtT20细胞中稳定表达时会内化。这些研究表明,CB1脱敏作用可由GRK调节,并且不同的受体结构域参与GRK和β-抑制蛋白依赖性脱敏作用以及CB1内化。